Top Stories
EMA is sending a survey out to pharmaceutical companies in the UK to gain information on their preparedness for Brexit.
/ read more /
The $11.6-billion acquisition would boost Sanofi's position in hematology and specialty medicines.
/ read more /
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
|
Industry News
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
/ read more /
The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.
/ read more /
More Industry News
|
|
|
|
Biopharma News
The company will invest $139 million in sterile manufacturing technology at its facility in Ballytivnan, Sligo, Ireland to support the growth of its oncology pipeline.
/ read more /
The acquisition builds on the companies’ earlier collaboration to develop T-cell-based therapeutics.
/ read more /
More Biopharma News
|
|
|
Supplier News
KBI Biopharma’s acquisition of Elion Labs expands KBI’s biophysical and analytical characterization capabilities.
/ read more /
Clover Biopharmaceuticals will use GE’s FlexFactory biomanufacturing platform with single-use bioreactors to produce innovative and biosimilar fusion protein products in China.
/ read more /
More Supplier News
|
|
|
Regulatory News
The FDA center released its list of planned guidance documents for the rest of the year.
/ read more /
|
|
|
The agencies sent warning letters to several companies that the agencies say are illegally marketing unapproved products to treat opioid addiction and withdrawal.
/ read more /
More Regulatory News
|
|
|
Events
February 7–8, 2018
February 11–14, 2018
March 12–14, 2018
more events
|
|
|
eBook
|
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.
|
|
|
|
|
|
